Mpm Bioventures Iv Strategic Fund, L.p. - Net Worth and Insider Trading
Mpm Bioventures Iv Strategic Fund, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mpm Bioventures Iv Strategic Fund, L.p. owns 2 companies in total, including Syndax Pharmaceuticals Inc (SNDX) , and Epizyme Inc (EPZM) .
Insider Ownership Summary of Mpm Bioventures Iv Strategic Fund, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2016-03-02 | 10 percent owner |
| EPZM | Epizyme Inc | 2013-05-30 | 10 percent owner |
Mpm Bioventures Iv Strategic Fund, L.p. Trading Performance
Mpm Bioventures Iv Strategic Fund, L.p. Ownership Network
Ownership Network List of Mpm Bioventures Iv Strategic Fund, L.p.
Ownership Network Relation of Mpm Bioventures Iv Strategic Fund, L.p.
Mpm Bioventures Iv Strategic Fund, L.p. Owned Company Details
What does Syndax Pharmaceuticals Inc do?
Who are the key executives at Syndax Pharmaceuticals Inc?
Mpm Bioventures Iv Strategic Fund, L.p. is the 10 percent owner of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .
Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary
Over the past 18 months, Mpm Bioventures Iv Strategic Fund, L.p. made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 211,420 shares made by Briggs Morrison , a net purchase of 673 shares made by Keith A. Goldan , and a net sale of 83,000 shares made by William Meury .
In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,997 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 293,747 shares.
Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syndax Pharmaceuticals Inc Insider Transactions
Mpm Bioventures Iv Strategic Fund, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Mpm Bioventures Iv Strategic Fund, L.p.. You might contact Mpm Bioventures Iv Strategic Fund, L.p. via mailing address: C/o Mpm Asset Management, 200 Clarendon Street, 54th Floor, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
